STOCK TITAN

Spectrum Pharmaceuticals, Inc. - SPPI STOCK NEWS

Welcome to our dedicated news page for Spectrum Pharmaceuticals (Ticker: SPPI), a resource for investors and traders seeking the latest updates and insights on Spectrum Pharmaceuticals.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Spectrum Pharmaceuticals's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Spectrum Pharmaceuticals's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.72%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.54%
Tags
earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.83%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
18.84%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.77%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.72%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.41%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.53%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.27%
Tags
none
Spectrum Pharmaceuticals, Inc.

Nasdaq:SPPI

SPPI Rankings

SPPI Stock Data

211.40M
Pharmaceutical Preparation Manufacturing
Manufacturing
Link

About SPPI

spectrum's core mission is to bring pharmaceutical products to patients for unmet medical needs. to this mission, we bring our years of drug development expertise, coupled with the insight of working in many different oncology indications. spectrum and its subsidiaries have six marketed oncology/hematology products, three for different types of non-hodgkins lymphoma, one for advanced metastatic colorectal cancer, one for a certain type of acute lymphoblastic leukemia (all) and one for multiple myeloma. there are two products in late-stage development, as well as a broad and diversified portfolio of proprietary drugs in various stages of development, all with a focus on oncology and hematology.